Please use this identifier to cite or link to this item:
|Title:||Positively selected G6PD-mahidol mutation reduces Plasmodium vivax density in Southeast Asians|
Nan M. Laird
Institut Pasteur, Paris
CNRS Centre National de la Recherche Scientifique
Harvard School of Public Health
|Citation:||Science. Vol.326, No.5959 (2009), 1546-1549|
|Abstract:||Glucose-6-phosphate dehydrogenase (G6PD) deficiency - the most common known enzymopathy - is associated with neonatal jaundice and hemolytic anemia usually after exposure to certain infections, foods, or medications. Although G6PD-deficient alleles appear to confer a protective effect against malaria, the link with clinical protection from Plasmodium infection remains unclear. We investigated the effect of a common G6PD deficiency variant in Southeast Asia-the G6PD-Mahidol487A variant - on human survival related to vivax and falciparum malaria. Our results show that strong and recent positive selection has targeted the Mahidol variant over the past 1500 years. We found that the G6PD-Mahidol487A variant reduces vivax, but not falciparum, parasite density in humans, which indicates that Plasmodium vivax has been a driving force behind the strong selective advantage conferred by this mutation.|
|Appears in Collections:||Scopus 2006-2010|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.